Circulating antiangiogenic proteins in obstructive sleep apnea and hypertension

Respiratory Medicine

Volumn 105, Issue 5, 2011, Pages 801-807

  Mohsenin, Vahid ^a   Urbano, Fred ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Catecholamines; Endoglin; Hypertension; Nitric oxide; sFlt 1; Sleep apnea

Indexed keywords

ADRENALIN; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOGLIN; ENDOTHELIN 1; NITRATE; NITRIC OXIDE; NITRITE; NORADRENALIN; VASCULOTROPIN RECEPTOR 1;

ADRENALIN BLOOD LEVEL; ADULT; ANTIHYPERTENSIVE THERAPY; APNEA HYPOPNEA INDEX; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLITE; NORADRENALIN BLOOD LEVEL; OBESITY; OXYGEN SATURATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME;

ANTIGENS, CD; CARDIOVASCULAR DISEASES; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EPINEPHRINE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITRIC OXIDE; NOREPINEPHRINE; POLYSOMNOGRAPHY; RECEPTORS, CELL SURFACE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 79953023700     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.01.001     Document Type: Article

References (53)

1. T. Young, M. Palta, J. Dempsey, J. Skatrud, S. Weber, and S. Badr The occurrence of sleep-disordered breathing among middle-aged adults N Engl J Med 328 17 1993 1230 1235 (Pubitemid 23115702)
2. T. Young, P. Peppard, and D. Gottlieb Epidemiology of obstructive sleep apnea: a population health perspective Am J Respir Crit Care Med 165 9 2002 1217 1239 (Pubitemid 34461732)
3. J. Hung, E.G. Whitford, R.W. Parsons, and D.R. Hillman Association of sleep apnoea with myocardial infarction in men Lancet 336 8710 1900 261 264
4. F.J. Nieto, T.B. Young, B.K. Lind, E. Shahar, J.M. Samet, S. Redline, R.B. D'Agostino, A.B. Newman, M.D. Lebowitz, and T.G. Pickering Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study JAMA 283 14 2000 1829 1836 (Pubitemid 30207619)
5. P.E. Peppard, T. Young, M. Palta, and J. Skatrud Prospective study of the association between sleep-disordered breathing and hypertension N Engl J Med 342 19 2000 1378 1384 (Pubitemid 30262394)
6. C. Sahlin, O. Sandberg, Y. Gustafson, G. Bucht, B. Carlberg, H. Stenlund, and K.A. Franklin Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up Arch Intern Med 168 3 2008 297 301 (Pubitemid 351281676)
7. E. Shahar, C.W. Whitney, S. Redline, E.T. Lee, A.B. Newman, F. Javier Nieto, G.T. O'Connor, L.L. Boland, J.E. Schwartz, and J.M. Samet Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health study Am J Respir Crit Care Med 163 2001 19 25 (Pubitemid 32095247)
8. H.K. Yaggi, J. Concato, W.N. Kernan, J.H. Lichtman, L.M. Brass, and V. Mohsenin Obstructive sleep apnea as a risk factor for stroke and death N Engl J Med 353 19 2005 2034 2041 (Pubitemid 41609096)
9. R. Wolk, A.S. Shamsuzzaman, and V.K. Somers Obesity, sleep apnea, and hypertension Hypertension 42 6 2003 1067 1074 (Pubitemid 37549057)
10. E. Fletcher, J. Miller, J. Schaaf, and F. Jg Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension Sleep 10 1987 35 44
11. H. Minemura, T. Akashiba, H. Yamamoto, T. Akahoshi, N. Kosaka, and T. Horie Acute effects of nasal continuous positive airway pressure on 24-hour blood pressure and catecholamines in patients with obstructive sleep apnea Intern Med 37 12 1998 1009 1013
12. D.S. Moller, P. Lind, B. Strunge, and E.B. Pedersen Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea Am J Hypertens 16 4 2003 274 280 (Pubitemid 36384754)
13. B.G. Phillips, K. Narkiewicz, C.A. Pesek, W.G. Haynes, M.E. Dyken, and V.K. Somers Effects of obstructive sleep apnea on endothelin-1 and blood pressure J Hypertens 17 1 1999 61 66 (Pubitemid 29086189)
14. S. Takahashi, Y. Nakamura, T. Nishijima, S. Sakurai, and H. Inoue Essential roles of angiotensin II in vascular endothelial growth factor expression in sleep apnea syndrome Respir Med 99 9 2005 1125 1131 (Pubitemid 41102649)
15. A. Barcelo, M. de la Pena, O. Ayllon, M.V. Vega-Agapito, J. Pierola, G. Perez, C. Gonzalez, A. Alonso, and A.G. Agusti Increased plasma levels of asymmetric dimethylarginine and soluble CD40 ligand in patients with sleep apnea Inter Rev Thorac Dis 77 1 2009 85 90 Respiration
16. P.H. Gjorup, L. Sadauskiene, J. Wessels, O. Nyvad, B. Strunge, and E.B. Pedersen Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease Am J Hyperten 20 1 2007 44 52 (Pubitemid 46014056)
17. F. Grimpen, P. Kanne, E. Schulz, G. Hagenah, G. Hasenfuss, and S. Andreas Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea Eur Respir J 15 2 2000 320 325 (Pubitemid 30085960)
18. J. Krieger, M. Schmidt, E. Sforza, L. Lehr, J.L. Imbs, G. Coumaros, and D. Kurtz Urinary excretion of guanosine 3′:5′-cyclic monophosphate during sleep in obstructive sleep apnoea patients with and without nasal continuous positive airway pressure treatment Clin Sci (Lond) 76 1 1989 31 37 (Pubitemid 19039088)
19. H. Krum, R.J. Viskoper, Y. Lacourciere, M. Budde, and V. Charlon The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators N Engl J Med 338 12 1998 784 790 (Pubitemid 28135984)
20. O. Marrone, L. Riccobono, A. Salvaggio, A. Mirabella, A. Bonanno, and M.R. Bonsignore Catecholamines and blood pressure in obstructive sleep apnea syndrome Chest 103 3 1993 722 727 (Pubitemid 23086163)
21. V. Mohsenin, H.K. Yaggi, N. Shah, and J. Dziura The effect of gender on the prevalence of hypertension in obstructive sleep apnea Sleep Med 10 7 2009 759 762
22. B.G. Phillips, and V.K. Somers Hypertension and obstructive sleep apnea Cur Hypertens Rep 5 5 2003 380 385 (Pubitemid 38898961)
23. C.L. Phillips, and P.A. Cistulli Obstructive sleep apnea and hypertension: epidemiology, mechanisms and treatment effects Minerva Med 97 4 2006 299 312 (Pubitemid 44687356)
24. A. Atkeson, S.Y. Yeh, A. Malhotra, and S. Jelic Endothelial function in obstructive sleep apnea Prog Cardiovasc Dis 51 5 2009 351 362
25. C.W. Redman, and I.L. Sargent Placental stress and pre-eclampsia: a revised view Placenta 30 Suppl. A 2009 S38 S42
26. T. Sanchez-Elsner, L.M. Botella, B. Velasco, C. Langa, and C. Bernabeu Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways J Biol Chem 277 46 2002 43799 43808 (Pubitemid 36157800)
27. J.M. Foidart, J.P. Schaaps, F. Chantraine, C. Munaut, and S. Lorquet Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia-a step forward but not the definitive answer J Reprod Immunol 82 2 2009 106 111
28. G.S. Di Marco, S. Reuter, U. Hillebrand, S. Amler, M. Konig, E. Larger, H. Oberleithner, E. Brand, H. Pavenstadt, and M. Brand The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD J Am Soc Nephrol 20 10 2009 2235 2245
29. K. Onoue, S. Uemura, Y. Takeda, S. Somekawa, H. Iwama, T. Nishida, Y. Morikawa, H. Nakagawa, T. Tsutsumi, J.H. Sung, Y. Takemoto, T. Soeda, S. Okayama, K. Ishigami, H. Kawata, M. Horii, T. Nakajima, and Y. Saito Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction Am J Cardiol 104 11 2009 1478 1483
30. S.A. Karumanchi, and I.E. Stillman In vivo rat model of preeclampsia Methods Mol Med 122 2006 393 399
31. F. Lu, M. Longo, E. Tamayo, W. Maner, A. Al-Hendy, G.D. Anderson, G.D. Hankins, and G.R. Saade The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice Am J Obstet Gynecol 196 4 2007 396 e391-397
32. S.E. Maynard, J.Y. Min, J. Merchan, K.H. Lim, J. Li, S. Mondal, T.A. Libermann, J.P. Morgan, F.W. Sellke, I.E. Stillman, F.H. Epstein, V.P. Sukhatme, and S.A. Karumanchi Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 5 2003 649 658 (Pubitemid 36278583)
33. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr., D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright Jr., and E.J. Roccella Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 42 6 2003 1206 1252 (Pubitemid 37553153)
34. V. Mohsenin Gender differences in the expression of sleep-disordered breathing: role of upper airway dimensions Chest 120 5 2001 1442 1447 (Pubitemid 33078455)
35. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force Sleep 22 5 1999 667 689
36. P. Hjemdahl Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection Methods Enzymol 142 1987 521 534 (Pubitemid 17086049)
37. D.L. Granger, R.R. Taintor, K.S. Boockvar, and J.B. Hibbs Jr. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction Methods Enzymol 268 1996 142 151 (Pubitemid 26286356)
38. P. Penev, K. Spiegel, T. Marcinkowski, and E. Van Cauter Impact of carbohydrate-rich meals on plasma epinephrine levels: dysregulation with aging J Clin Endocrinol Metab 90 11 2005 6198 6206 (Pubitemid 41606544)
39. M.G. Ziegler, R. Nelesen, P. Mills, S. Ancoli-Israel, B. Kennedy, and J.E. Dimsdale Sleep apnea, norepinephrine-release rate, and daytime hypertension Sleep 20 3 1997 224 231 (Pubitemid 27242272)
40. M.S. Ip, B. Lam, L.Y. Chan, L. Zheng, K.W. Tsang, P.C. Fung, and W.K. Lam Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure Am J Respir Crit Care Med 162 6 2000 2166 2171 (Pubitemid 32051681)
41. R. Schulz, D. Schmidt, A. Blum, X. Lopes-Ribeiro, C. Lucke, K. Mayer, H. Olschewski, W. Seeger, and F. Grimminger Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy Thorax 55 12 2000 1046 1051
42. E. Fletcher, J. Lesske, W. Qian, C.R. Miller, and T. Unger Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats Hypertension 19 1992 555 561
43. Y.J. Peng, and N.R. Prabhakar Effect of two paradigms of chronic intermittent hypoxia on carotid body sensory activity J Appl Physiol 96 3 2004 1236 1242 (discussion 1196) (Pubitemid 38248707)
44. A. Valipour, B. Litschauer, F. Mittermayer, H. Rauscher, O.C. Burghuber, and M. Wolzt Circulating plasma levels of vascular endothelial growth factor in patients with sleep disordered breathing Respir Med 98 12 2004 1180 1186 (Pubitemid 39497219)
45. O. Mir, S. Ropert, J. Alexandre, and F. Goldwasser Hypertension as a surrogate marker for the activity of anti-VEGF agents Ann Oncol 20 5 2009 967 970
46. A. Bergmann, S. Ahmad, M. Cudmore, A.D. Gruber, P. Wittschen, W. Lindenmaier, G. Christofori, V. Gross, A.C. da Costa Gonzalves, H.J. Grone, A. Ahmed, and H.A. Weich Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model J Cell Mol Med 2009
47. S. Cheifetz, T. Bellon, C. Cales, S. Vera, C. Bernabeu, J. Massague, and M. Letarte Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells J Biol Chem 267 27 1992 19027 19030
48. L.M. Botella, T. Sanchez-Elsner, F. Sanz-Rodriguez, S. Kojima, J. Shimada, M. Guerrero-Esteo, M.P. Cooreman, V. Ratziu, C. Langa, C.P. Vary, J.R. Ramirez, S. Friedman, and C. Bernabeu Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury Blood 100 12 2002 4001 4010 (Pubitemid 35396866)
49. S. Venkatesha, M. Toporsian, C. Lam, J. Hanai, T. Mammoto, Y.M. Kim, Y. Bdolah, K.H. Lim, H.T. Yuan, T.A. Libermann, I.E. Stillman, D. Roberts, P.A. D'Amore, F.H. Epstein, F.W. Sellke, R. Romero, V.P. Sukhatme, M. Letarte, and S.A. Karumanchi Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 6 2006 642 649 (Pubitemid 43865232)
50. M. Jerkic, J.V. Rivas-Elena, J.F. Santibanez, M. Prieto, A. Rodriguez-Barbero, F. Perez-Barriocanal, M. Pericacho, M. Arevalo, C.P. Vary, M. Letarte, C. Bernabeu, and J.M. Lopez-Novoa Endoglin regulates cyclooxygenase-2 expression and activity Circ Res 99 3 2006 248 256 (Pubitemid 44174932)
51. B. Barleon, P. Reusch, F. Totzke, C. Herzog, C. Keck, G. Martiny-Baron, and D. Marme Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors Angiogenesis 4 2 2001 143 154 (Pubitemid 34032700)
52. D. Li, H. Chen, and J.L. Mehta Angiotensin II via activation of type 1 receptor upregulates expression of endoglin in human coronary artery endothelial cells Hypertension 38 5 2001 1062 1067 (Pubitemid 34252806)
53. N.A. Chung, D.G. Beevers, and G. Lip Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension Blood Press 13 3 2004 183 189 (Pubitemid 38967763)